pindolol has been researched along with Arrhythmia in 61 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lorcainide, a new class I antiarrhythmic agent, was administered intravenously to eight patients with acute myocardial infarction for 24 hours, and thereafter given by mouth, 200 mg daily for ten days." | 9.05 | Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction. ( Gordin, A; Heikkilä, J; Leinonen, H; Sundberg, S, 1984) |
| "Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Viskén) combined with hydralazine." | 9.04 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. ( Persson, I, 1976) |
| "The effect of pindolol on experimental myocardial infarction was studied in a pig model." | 7.67 | Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig. ( Althaus, U; Friedli, HP; Gurtner, HP; Magnenat, L, 1986) |
| "The role of pindolol in treating ventricular arrhythmia was studied in 43 patients with this disorder." | 7.66 | Pindolol for ventricular arrhythmia. ( Lown, B; Podrid, PJ, 1982) |
| "The study was designed to assess the antiarrhythmic and antianginal properties of pindolol as well as the tolerance to the drug by patients who had experienced a myocardial infarction 5 to 6 months previously." | 7.66 | Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity. ( Roskamm, N; Samek, L; Sturzenhofecker, P; Welzel, D, 1982) |
| "In this study the anti-arrhythmic effectiveness of pindolol has been tested on ventricular effort arrhythmias in a group of 22 cardiopathic patients." | 7.66 | [Pindolol in the treatment of arrhythmias caused by exertion]. ( Giordano, A; Rossi, P; Schiavo, B; Tamiz, A, 1979) |
| "A study was designed to examine ventricular arrhythmias in the acute phase of experimental myocardial infarction in the pig and to evaluate possible antiarrhythmogenic influence of the beta-adrenergic blocking drug pindolol (Visken) and the calcium antagonist Ro 11-1781." | 7.66 | [Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781]. ( Althaus, U; Dolder, M; Frank, J; Gertsch, M; Gurtner, HP, 1978) |
| "The authors report four new cases of hyperthyroidism associated with prolonged treatment with amiodarone." | 7.65 | [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases]. ( Chapelle, M; Naouri, R; Wolff, F, 1976) |
| " Ambulatory electrocardiography was used to compare the effects of propranolol and pindolol on symptoms, heart rate, arrhythmias and ST segments." | 5.06 | The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography. ( Ballantyne, D; Northcote, RJ, 1988) |
| "Lorcainide, a new class I antiarrhythmic agent, was administered intravenously to eight patients with acute myocardial infarction for 24 hours, and thereafter given by mouth, 200 mg daily for ten days." | 5.05 | Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction. ( Gordin, A; Heikkilä, J; Leinonen, H; Sundberg, S, 1984) |
| "Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Viskén) combined with hydralazine." | 5.04 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. ( Persson, I, 1976) |
| "The effect of pindolol on experimental myocardial infarction was studied in a pig model." | 3.67 | Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig. ( Althaus, U; Friedli, HP; Gurtner, HP; Magnenat, L, 1986) |
| "Combination of the beta-adrenergic blocking agent visken with glucagon in the acute period of myocardial infarction possesses higher antiarrhythmic activity with a negligible cardiodepressive effect as compared to that of isolated administration of visken and leads to a decrease in the excessive production of catecholamines and glucocorticoids in the blood." | 3.66 | [Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct]. ( Golikov, AP; Ivleva, VI; Orlov, AI; Stepura, OB, 1980) |
| " However, in vitro experiments are not satisfactory to predict antiarrhythmic activity "in vivo", because: 1) they are mostly performed in preparations made from the normal myocardium; 2) "in vitro" the autonomic and hormonal effects are absent; 3) some drugs as nitroglycerin or strophanthin do not produce antiarrhythmic electrophysiological changes in "vitro" but under appropriate conditions they may have a clear-cut antiarrhythmic action "in vivo"; 4) arrhythmias mostly arise from the interaction of changes in several fundamental electrophysiological parameters which could be best studied "in vivo"." | 3.66 | [Pharmacologic evaluation of electrical processes in the myocardium]. ( Sekeresh, L, 1982) |
| " Lidocaine and pindolol pretreatment increased the survival rate and attenuated the life-threatening arrhythmias during the first 20 min, but did not influence the infarct size 16 hrs later." | 3.66 | Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. ( Koltai, M; Leprán, I; Siegmund, W; Szekeres, L, 1983) |
| "The role of pindolol in treating ventricular arrhythmia was studied in 43 patients with this disorder." | 3.66 | Pindolol for ventricular arrhythmia. ( Lown, B; Podrid, PJ, 1982) |
| "The study was designed to assess the antiarrhythmic and antianginal properties of pindolol as well as the tolerance to the drug by patients who had experienced a myocardial infarction 5 to 6 months previously." | 3.66 | Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity. ( Roskamm, N; Samek, L; Sturzenhofecker, P; Welzel, D, 1982) |
| "In this study the anti-arrhythmic effectiveness of pindolol has been tested on ventricular effort arrhythmias in a group of 22 cardiopathic patients." | 3.66 | [Pindolol in the treatment of arrhythmias caused by exertion]. ( Giordano, A; Rossi, P; Schiavo, B; Tamiz, A, 1979) |
| "To evaluate the ability of histamine to induce ventricular arrhythmias, we studied the effects of histamine on ventricular rhythmicity in the isolated guinea pig heart with complete atrioventricular conduction block." | 3.66 | Acceleration of idioventricular rhythms by histamine in guinea pig heart: mediation by H2 receptors. ( Levi, R; Zavecz, JH, 1979) |
| "A study was designed to examine ventricular arrhythmias in the acute phase of experimental myocardial infarction in the pig and to evaluate possible antiarrhythmogenic influence of the beta-adrenergic blocking drug pindolol (Visken) and the calcium antagonist Ro 11-1781." | 3.66 | [Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781]. ( Althaus, U; Dolder, M; Frank, J; Gertsch, M; Gurtner, HP, 1978) |
| "The authors report four new cases of hyperthyroidism associated with prolonged treatment with amiodarone." | 3.65 | [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases]. ( Chapelle, M; Naouri, R; Wolff, F, 1976) |
| "The utility of using beta blocking drugs, specifically Pindolol, as a prophylaxis for arrhythmia during cardiac microcatheterism according to Grandjean's technique has been observed." | 3.65 | [Prevention of arrhythmias during heart catheterization]. ( Di Napoli, T; di Quacquaro, GS; Giovine, F; Monaco, G, 1977) |
| "Oxprenolol or pindolol were used as primary drugs in 8 cases." | 1.26 | [Therapy of postoperative arrhythmias (author's transl)]. ( Vormittag, E, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (93.44) | 18.7374 |
| 1990's | 3 (4.92) | 18.2507 |
| 2000's | 1 (1.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groszek, G | 1 |
| Bednarski, M | 1 |
| Dybała, M | 1 |
| Filipek, B | 1 |
| Golikov, AP | 2 |
| Orlov, AI | 2 |
| Ivleva, VI | 1 |
| Stepura, OB | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Vaniev, SB | 1 |
| Berestov, AA | 1 |
| Maĭorov, NI | 1 |
| Frishman, WH | 2 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Leinonen, H | 1 |
| Heikkilä, J | 1 |
| Sundberg, S | 1 |
| Gordin, A | 1 |
| Sekeresh, L | 1 |
| Leprán, I | 1 |
| Koltai, M | 1 |
| Siegmund, W | 1 |
| Szekeres, L | 2 |
| Podrid, PJ | 1 |
| Lown, B | 1 |
| Welzel, D | 1 |
| Roskamm, N | 1 |
| Samek, L | 2 |
| Sturzenhofecker, P | 1 |
| Roskamm, H | 1 |
| Satoh, H | 1 |
| Hisatome, I | 1 |
| Arita, M | 1 |
| Zamotaev, IP | 2 |
| Lozinskiĭ, LG | 2 |
| Sandomirskiĭ, BL | 2 |
| Maksimova, LN | 1 |
| Erding, E | 1 |
| Nalbantgil, E | 1 |
| Kiliccioglu, B | 1 |
| Nalbantgil, I | 1 |
| Vidinel, I | 1 |
| Frishman, W | 1 |
| Davis, R | 1 |
| Strom, J | 1 |
| Elkayam, U | 1 |
| Stampfer, M | 1 |
| Ribner, H | 1 |
| Weinstein, J | 1 |
| Sonnenblick, E | 1 |
| Giordano, A | 1 |
| Tamiz, A | 1 |
| Schiavo, B | 1 |
| Rossi, P | 1 |
| Vormittag, E | 1 |
| Doshchitsin, VL | 1 |
| Frisch, P | 1 |
| Levi, R | 1 |
| Zavecz, JH | 1 |
| Frank, J | 1 |
| Dolder, M | 1 |
| Gertsch, M | 1 |
| Althaus, U | 2 |
| Gurtner, HP | 2 |
| Persson, I | 1 |
| Chapelle, M | 1 |
| Naouri, R | 1 |
| Wolff, F | 1 |
| di Quacquaro, GS | 1 |
| Giovine, F | 1 |
| Di Napoli, T | 1 |
| Monaco, G | 1 |
| Zdichynec, B | 1 |
| Dubova, MN | 1 |
| Zisel'man, SB | 1 |
| Pankratov, AB | 1 |
| Offenstadt, G | 1 |
| Hericord, PH | 1 |
| Amstrutz, PH | 1 |
| Latorre, A | 1 |
| Lenti, M | 1 |
| Calabrese, P | 1 |
| Miyazaki, M | 1 |
| Nioka, S | 1 |
| Fujita, T | 1 |
| Koaté, P | 1 |
| Diouf, S | 1 |
| Diouf, D | 1 |
| Essalai, M | 1 |
| Santini, M | 1 |
| Dini, P | 1 |
| Di Mascolo, R | 1 |
| Milazzotto, F | 1 |
| Jacovella, G | 1 |
| Molenaar, P | 1 |
| Russell, FD | 1 |
| Shimada, T | 1 |
| Summers, RJ | 1 |
| Sugiyama, S | 1 |
| Hattori, M | 1 |
| Miyazaki, Y | 1 |
| Nagai, S | 1 |
| Ozawa, T | 1 |
| Northcote, RJ | 1 |
| Ballantyne, D | 1 |
| Knüttgen, D | 1 |
| Doehn, M | 1 |
| Friedli, HP | 1 |
| Magnenat, L | 1 |
| Oulhaci, M | 1 |
| Merad, B | 1 |
| Toumi, N | 1 |
| Ait-Amar, M | 1 |
| Boudjellab, A | 1 |
| Issad, M | 1 |
| Piva, G | 1 |
| Färber, A | 1 |
| Kenedi, I | 1 |
| Losonci, A | 1 |
| Gross, F | 1 |
| Bhargava, KP | 1 |
| Gupta, MC | 1 |
| Mathur, KS | 1 |
| Dalal, S | 1 |
| Maruyama, S | 1 |
| Ducloux, M | 1 |
| Singh, BN | 2 |
| Offerhaus, L | 1 |
| Jewitt, DE | 1 |
| Goch, JH | 1 |
| Damany, SJ | 1 |
| Bhatt, GR | 1 |
| Tikare, SK | 1 |
| Thaly, KG | 1 |
| Gupta, PS | 1 |
| Bisht, DB | 1 |
| Banerji, K | 1 |
| Chaubey, BS | 1 |
| Attal, HC | 1 |
| Pretolani, E | 1 |
| Zoli, I | 1 |
| Addarii, F | 1 |
| Meier, J | 1 |
| Baranowski, E | 1 |
| Wagner, E | 1 |
| Waucampt, JJ | 1 |
| Decalf, A | 1 |
| Delmon, A | 1 |
| Goethals, S | 1 |
| Pauchant, M | 1 |
| Somani, P | 1 |
| Kumakura, S | 1 |
7 reviews available for pindolol and Arrhythmia
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity.
Topics: Animals; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Child; Coronary Disease; Female; Human | 1983 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
10 trials available for pindolol and Arrhythmia
| Article | Year |
|---|---|
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Clinical Tria | 1984 |
[Comparative evaluation of the clinical action of a series of beta-adrenergic blockaders].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Bronchi; Clinical Trials as Topi | 1976 |
[Prevention by pindolol of electrocardiographic changes during bronchoscopy performed under local and general anesthesia].
Topics: Adult; Aged; Anesthesia, Inhalation; Anesthesia, Local; Arrhythmias, Cardiac; Bronchoscopy; Drug Eva | 1977 |
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydr | 1976 |
[Treatment of disorders of cardiac rhythm with beta-adrenoblockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Tri | 1985 |
The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Electrocardiography; Heart Rate; Humans; Male; M | 1988 |
[Pindolol in intraoperatively developing isorhythmic AV dissociation].
Topics: Adult; Arrhythmias, Cardiac; Atrioventricular Node; Electrocardiography; Female; Heart Conduction Sy | 1987 |
Visken (LB-46) a double blind cross-over study in cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Hyperthyroidism; Pindolol; Placebos; Propran | 1972 |
A new beta-adrenergic blocking agent in cardiac arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; Male; Middle Aged; Pindolol; Pla | 1972 |
45 other studies available for pindolol and Arrhythmia
| Article | Year |
|---|---|
Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
Topics: 2-Propanol; Adrenergic Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroca | 2009 |
[Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catecholamin | 1980 |
[Use of beta-adrenoblockaders in the therapy of the syndromes accompanying acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Hemodynamics; Humans | 1981 |
[Pharmacologic evaluation of electrical processes in the myocardium].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Drug Evaluation | 1982 |
Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Disease Models, Animal; Lidocaine | 1983 |
Pindolol for ventricular arrhythmia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Evaluation; Exercise Test; Female; Heart Ventricles; Humans; | 1982 |
Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity.
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Drug Evaluation; Exercise Test; Heart Rate; Humans; Mi | 1982 |
Antianginal and antiarrhythmic effects of pindolol in post-infarct patients.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Heart Rate; Humans; Myocardial Infarction; Physical Exertion; | 1982 |
Modulation of the automaticity by histamine and cimetidine in rabbit sino-atrial node cells.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cell Membrane; Cimetidine; Electrophysiology; Hear | 1993 |
Effects of catecholamines on the residual sodium channel dependent slow conduction in guinea pig ventricular muscles under normoxia and hypoxia.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels; Catecholamines; Dose-Response Re | 1995 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Bronchial Spas | 1979 |
[Pindolol in the treatment of arrhythmias caused by exertion].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Pindolol | 1979 |
[Therapy of postoperative arrhythmias (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complex | 1979 |
[Comparative evaluation of new drugs used in the treatment of cardiac arrhythmia].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Ajmaline; Alprenolol; Anti-Arrhythmia Agents; Arr | 1975 |
Acceleration of idioventricular rhythms by histamine in guinea pig heart: mediation by H2 receptors.
Topics: Anaphylaxis; Animals; Arrhythmias, Cardiac; Chlorpheniramine; Cimetidine; Dose-Response Relationship | 1979 |
[Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781].
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Calcium; Female; Myocardial Infarction; Pindolol; Swin | 1978 |
[Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases].
Topics: Adult; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; | 1976 |
[Prevention of arrhythmias during heart catheterization].
Topics: Arrhythmias, Cardiac; Cardiac Catheterization; Heart Rate; Humans; Pindolol | 1977 |
[Treatment of supraventricular arrhythmias using the beta-blockader Visken].
Topics: Arrhythmias, Cardiac; Blood Pressure; Female; Heart Rate; Heart Ventricles; Humans; Male; Pindolol | 1977 |
[Use of beta adrenergic receptor blockaders in the early postoperative period].
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Evaluation; Humans; Middle Aged; Oxprenolol; Pindolol; Posto | 1977 |
[Letter: Voluntary poisoning with pindolol].
Topics: Adult; Arrhythmias, Cardiac; Coma; Female; Humans; Hypertension; Pindolol; Substance-Related Disorde | 1976 |
[LB-46 in the treatment of angina pectoris, arrhythmia and functional cardiac disorders].
Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Female; | 1976 |
[Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin)].
Topics: Adult; Alprenolol; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Dogs; Enflurane; Halothane | 1975 |
[Use of a beta blocker--the LB 46--in the treatment of certain arrhythmias].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Drug Evaluation; Female; Humans; Male; Middle Aged; Pindolo | 1975 |
[Effects of pindolol on the automatism of the sinus node and on atrioventricular and intraventricular conduction in man].
Topics: Arrhythmias, Cardiac; Atrioventricular Node; Bundle of His; Female; Heart Conduction System; Humans; | 1975 |
Densitometric analysis of beta 1- and beta 2-adrenoceptors in guinea-pig atrioventricular conducting system.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Autoradiography; | 1990 |
Mechanism of antiarrhythmic action of beta-blocking agents.
Topics: Acebutolol; Acyl Coenzyme A; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; Ca | 1985 |
Cardioprotection by anti-ischaemic and cytoprotective drugs.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden; Dietary Fats; Epoprostenol; Humans; | 1987 |
Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig.
Topics: Animals; Arrhythmias, Cardiac; Female; Hemodynamics; Myocardial Infarction; Pindolol; Swine | 1986 |
[A new beta-blocker, LB 46--Visken].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Heart Defects, Congenital; Huma | 1973 |
[Treatment of tachycardias and arrhythmias. Studies using Visken].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Coronary Di | 1974 |
Effect of beta adrenergic blocking on the arrhythmias following coronary ligation in rat.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmia, Sinus; Arrhythmias, Cardiac; Cardiac Complexes, Pr | 1973 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
On the importance of a central beta-adrenoceptor site in the antiarrhythmic activity of beta-blockers.
Topics: Aconitum; Adrenal Glands; Adrenergic beta-Antagonists; Alprenolol; Animals; Arrhythmias, Cardiac; Ca | 1972 |
Anti-arrhythmic effects of LB-46 on experimentally produced digitoxic arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Digoxin; Dogs; Female; Male; Pindolol | 1972 |
Electrophysiological evidence of the initiation of arrhythmia by beta-adrenergic blocking agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Dogs; Female; Heart C | 1973 |
[Pindolol in foreign medical practice].
Topics: Adrenergic beta-Antagonists; Adult; Africa, Northern; Angina Pectoris; Arrhythmias, Cardiac; Arterio | 1973 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Fail | 1973 |
[Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Amino Alcohols; Arrhythmias, Cardiac; Evaluation S | 1972 |
LB-46 in cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Digoxin; Female; Heart Rate; Hum | 1972 |
Treatment of digitalis induced arrhythmias with LB-46 (Visken).
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Digitalis Glycosides; Electrocardiography; Female; Hu | 1972 |
[Pharmacological treatment associated with the insertion of a demand pacemaker in the atrial rhythm disease. Prearranged commentary on the report of Scardi and collaborators].
Topics: Ajmaline; Arrhythmias, Cardiac; Electrocardiography; Glucagon; Heart Block; Humans; Pacemaker, Artif | 1973 |
[Experimental studies on the cardio-selectivity of pindolol. Studies on healthy subjects, and patients with bronchitis and asthma].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Asthma; Bronchitis; Heart; Humans; Metaproterenol; Pindolol; | 1973 |
[Visken. Study of its action on atrial rhythm disorders and on chronic insufficiency. Apropos of 50 cases].
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Drug Evaluation; Heart Atria; Humans; Middle Aged; Pin | 1973 |
Anti-arrhythmic action of beta-adrenergic receptor blocking agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digitalis Glycosides; Dogs | 1973 |